| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc. | Director | Common Stock | 2.5K | $121K | $48.42 | Jun 11, 2025 | Direct |
| Mirum Pharmaceuticals, Inc. | Director | Restricted Stock Units | 0 | $120K | $21.05 | May 29, 2025 | Direct |
| KalVista Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 30K | Oct 1, 2025 | Direct | ||
| Rein Therapeutics, Inc. | Director | Stock Option (right to buy) | 17.5K | Jul 23, 2025 | Direct | ||
| Mirum Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 6.27K | May 29, 2025 | Direct | ||
| Mirum Pharmaceuticals, Inc. | Director | Deferred Stock Units | 3.98K | May 29, 2025 | Direct |